Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

An Open Label Access Study For Subjects Who Completed A1481156

Expanded access is temporarily not available for this treatment.
Sponsor:
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT01582438
First received: April 19, 2012
Last updated: February 9, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is temporarily not available for this treatment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given